- Home
- / Adecto Pharmaceuticals
Adecto Pharmaceuticals
Adecto Pharmaceuticals Summary
Company Summary
- Overview
- Adecto Pharmaceuticals is a cancer therapeutics company. It develops an antibody-based therapy for triple-negative breast cancers and antibody-based therapy against ADAM8-expressing cancers and an immunohistochemistry (IHC)-based diagnostic.
- Type
- Private
- Status
- Active
- Founded
- 2014
- HQ
- Boston, MA, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Nora D. Mineva, Co-Founder & Chief Scientific Officer
Mathilde Romagnoli, Co-Founder & Advisor - Strategic Planning & Scientific Approach
LocationsView all
1 location detected
Boston, MA HQ
United States
75 Kneeland Street,14th floor